Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Pumpkin seed oil may improve prostate health, bladder control, and hair growth in men.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Alopecia causes significant emotional distress and psychological issues, requiring combined skin and mental health treatment.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Hair transplantation improves life quality and self-esteem in men with male pattern baldness.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

AGA patients have a lower quality of life than AA patients.

Low quality of life and high HSS-29 scores increase risk of losing patients during treatment.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

More severe hair loss worsens quality of life in men.

Online medical education helps doctors better understand and treat nail fungus.

OCT is a reliable, noninvasive way to measure hair thickness.

Videodermoscopy better identifies female hair loss than clinical diagnosis.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Watercress oil may promote hair growth by activating specific receptors.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.